THE ROLE OF RADIODIAGNOSIS OF NECROTIZING ENTEROCOLITIS IN PREMATURE INFANTS.

Necrotizing enterocolitis (NEC) is the most often encountered pathology of newborns and always requires an emerging surgery in cases of perforation. An active study of more important diagnostic factors at early stages of a disease is one of the first aims of neonatologists and pediatric surgeons. This study was therefore designed to examine the state of diagnostic problems in patients presenting with Necrotizing enterocolitis, identification of possible ways of the improvement of a patient's diagnosis suffering from Necrotizing enterocolitis and patients with perforated enterocolitis, definition of the possibilities of roentgenologic methods for the determination of a disease stage of Necrotizing enterocolitis. 69 infants aged one day to 1.5 months admitted at surgical department of K.Y. Farajeva Research Institute of Pediatrics between 2016 and 2021 inclusive were treated and evaluated. The capabilities of plain radiography and using radiocontrast methods of study to reveal NEC stages have been evaluated. The use of CSM has advantages: simplicity and accessibility in use, high diagnostic informativeness, identification of objective signs of NEC in 2-3 hours of research, allows assessing the severity of the patient's condition at an early date and timely correct treatment.

Assessment of adherence to antithrombotic therapy in patients with atrial fibrillation during the COVID-19 pandemic.

INTRODUCTION: Despite epidemiological evidence linking COVID-19 with cardiovascular diseases, little is known about whether and how coronavirus infection (CVI) influences atrial fibrillation (AF), the most prevalent arrhythmia in clinical practice. MATERIALS AND METHODS: We examined 621 patients with AF using the Morisky-Green scale (MMAS-4) criteria to assess adherence to antithrombotic therapy. They received inpatient treatment during the COVID-19 pandemic. RESULTS: A total of 118 patients out of 621 underwent CVI. Most patients had mild (33.9%) and moderate (49.15%) CVI. We managed to confirm the data of studies by foreign authors, according to which treatment with anticoagulants for at least 1 month reduces the severity of coronavirus infection, as well as protects against thrombotic complications. CONCLUSION: It is necessary to improve the management of AF, especially if someone was infected with COVID-19. The susceptibility to AF is increased in the acute phase of COVID-19 infection. Personal electrocardiogram devices as well as remote monitoring (teleconsultations) could optimise the care of such patients.

Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.

Treatment of metastatic soft tissue sarcoma (mSTS) commonly includes multiple lines of chemotherapy, until a decline in performance status precludes further treatment. The primary objective of this study was to describe the lifetime healthcare resource utilisation and cost among mSTS patients with favourable response to chemotherapy. SABINE was a multi-centre (n = 25), multi-country (n = 9) retrospective chart review study of mSTS patients with favourable response to chemotherapy following 4 cycles. Healthcare resource utilisation was collected from first line until death or end of follow-up. Costs were analysed by health states (defined by treatment line, chemotherapy use and disease progression) and estimated by multiplying the mean weekly cost per health state by the expected number of weeks spent in each health state. Expected per-patient lifetime medical cost was €65 616 (95% CI: €51 454-€85 003); comprised of IV chemotherapy (31.7%), inpatient care (24.8%), concomitant medication (11.0%), oral chemotherapy (8.9%), outpatient visits (8.8%), radiotherapy (6.3%), hospice (4.0%), imaging (3.7%) and laboratory (0.7%). Weekly costs were 280-330% higher during chemotherapy treatment periods than off-chemotherapy, especially after disease progression. Per-patient costs were highest in the USA and lowest in the Netherlands and UK. The economic burden of mSTS is considerable and the amount of resources devoted to its treatment varies across countries.

Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.

BACKGROUND: To describe chemotherapy treatment patterns and clinical outcomes in metastatic soft tissue sarcoma (mSTS) patients with favorable response to chemotherapy. PATIENTS AND METHODS: Multicenter (25) multi-country (9) retrospective chart review of mSTS patients with favorable response to chemotherapy, defined as stable disease or better following four cycles. RESULTS: Two hundred and thirteen patients (58% female; mean age 54.7 years) received a mean of 2.7 lines of chemotherapy and 5.2 cycles per line. The most common first-line regimens were doxorubicin (34%) and anthracycline plus ifosfamide (30%). Favorable response was achieved by 83% to first-line and 42% and 38% in second- and third-line chemotherapy. The most common reason for chemotherapy discontinuation in lines with a favorable response was reaching a predefined number of cycles in first line (64% of 213) and disease progression in second or later lines (41% of 138). The mean time off chemotherapy was 38.0 weeks after first line, falling to 2.7-6.4 weeks in second or later lines. Median overall and progression-free survival were 23.5 (95% confidence interval 20.5-28.1) and 8.3 (7.4-9.9) months from first favorable response to chemotherapy. CONCLUSIONS: mSTS patients achieving favorable response to chemotherapy have poor outcomes. Additional treatment options are needed.

The multivariate analysis of indications of rigid bronchoscopy in suspected foreign body aspiration.

OBJECTIVE: Foreign body aspiration (FBA) could be a serious life-threatening condition in children. Patients usually underwent bronchoscopy with suspicious of FBA alone. In this study, we aimed to determine which patients need to go to bronchoscopy based on pre-operative findings. METHODS: Retrospective analysis of patients underwent bronchoscopy between 1999 and 2015 was performed. Clinical symptoms, witnessed aspiration event (WAE), physical examination findings (PEFs) and radiological findings (RFs) were analyzed by multivariate analysis to evaluate the indications of bronchoscopy. RESULTS: 431 patients (266M, 165F) underwent bronchoscopy with a median age of 2 years (7 months-16 years). A foreign body was detected in 68% of the patients. Univariate analysis demonstrated that wheeze was the sole distinctive clinical symptom for detection of FBA (p<0.001). The rates of positive WAE, PEFs and RFs were 83%, 71.7% and 36.9%, respectively. All of them were identified as independent predictive parameters in the detection of FBA by univariate analysis (p = 0.003&p<0.001&p = 0.015). Multivariate analysis was performed with considering the association between them. The rate of positive bronchoscopy was 91.3% in patients with positive WAE, PEFs and RFs together(84/92). In patients with a positive WAE alone who had not got PEFs and RFs, the rate of positive bronchoscopy was 34.2% (25/73). A foreign body was detected in 84% of the patients who had not got a WAE but positive PEFs and RFs together(21/25). Bronchial laceration was occurred in one patient during bronchoscopy. Pneumothorax was not seen in any of the other patients. The rate of mortality was 0.4% in the overall group (2 patients). CONCLUSION: The indications of bronchoscopy in suspected FBA are usually based on clinical suspicious. The definition of " suspicous" could be a WAE or positive PEFs and RFs. The association of these factors increase the rate of positive bronchoscopies. In the light of our study, the classical indication for suspected FBA is still valid as "suspicious requires bronchoscopy".